BridgeBio gears up for FDA review of acoramidis following Phase III results

BridgeBio gears up for FDA review of acoramidis following Phase III results

Submitted by admin on January 11, 2024 - 11:07am
Source: 
Clinical Trials Arena
News Tags: 
BridgeBio
FDA
acoramidis
clinical trials
Headline: 
BridgeBio gears up for FDA review of acoramidis following Phase III results
snippet: 

BridgeBio submitted the NDA with US FDA for the TTR stabiliser in December 2023 and plans to engage with other regulatory bodies this year.

Do Not Allow Advertisers to Use My Personal information